Eagle Pharmaceuticals (EGRX) Tops Q1 EPS by 33c; Offers FY23 EPS Guidance

Go back to Eagle Pharmaceuticals (EGRX) Tops Q1 EPS by 33c; Offers FY23 EPS Guidance
EAGLE PHARMACEUT (NASDAQ: EGRX) Delayed: 2.14 --0 (-0%)
Previous Close $2.14    52 Week High $102.48 
Open $2.14    52 Week Low $33.02 
Day High $2.14    P/E N/A 
Day Low $2.14    EPS $-1.02 
Volume 9,360